SBSavannah L. Bergquist

Savannah L. Bergquist

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Savannah L. Bergquist has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hospitalizations reduce health care utilization of household members

    by Savannah Bergquist, Mathijs de Vaan

    Objective: To examine whether the financial burden of hospitalizations affects the health care utilization of household members of the admitted patient.Data Sources: We utilized health care claims data from the Massachusetts All‐Payer Claims Database, 2010–2015, to identify emergency hospitalizations of patients on family insurance plans and the health care utilization of the family members on those plans.Study Design: We used an event‐study analysis to compare health care spending and utilization of family members of a hospitalized individual and family members of an individual who was hospitalized 1 year later. We examine whether such hospitalizations were associated with changes in medical spending, the frequency of ambulatory office visits, other ambulatory care, and preventive care.Data Collection/Extraction Methods: The analyses include household members of patients with an emergency admission and a length of stay between 5 and 90 days.Principal Findings: Unexpected hospital admissions reduced household members' health care spending and utilization by more than 6.4% (95% confidence interval [CI]: −8.2%, −4.5%) on average in the year following the hospitalization. Household members had fewer ambulatory visits with primary care physicians (PCPs), fewer referrals to specialists, and reduced utilization of other ambulatory care, including high‐value preventive services. These changes were observed for both children and adults and were exacerbated if members of the household had previously been on Medicaid. The reduction in utilization was less pronounced when the admitted patient and household member shared the same PCP and when their health insurance plan had a family deductible.Conclusions: Compared with families without a hospitalized family member, family members of hospitalized individuals reduced their medical spending and utilization, including a substantial reduction in the use of preventive care. This study highlights the challenges of providing continuity in care when families face financial hardship.


  • Open Access

    Uncertainty in lung cancer stage for survival estimation via set‐valued classification

    by Savannah Bergquist, Gabriel A. Brooks, Mary Beth Landrum, Nancy L. Keating, Sherri Rose

    The difficulty in identifying cancer stage in health care claims data has limited oncology quality of care and health outcomes research. We fit prediction algorithms for classifying lung cancer stage into three classes (stages I/II, stage III, and stage IV) using claims data, and then demonstrate a method for incorporating the classification uncertainty in survival estimation. Leveraging set‐valued classification and split conformal inference, we show how a fixed algorithm developed in one cohort of data may be deployed in another, while rigorously accounting for uncertainty from the initial classification step. We demonstrate this process using SEER cancer registry data linked with Medicare claims data.


  • Data transformations to improve the performance of health plan payment methods

    by Savannah L. Bergquist, Timothy J. Layton, Thomas G. McGuire, Sherri Rose


  • Sample Selection for Medicare Risk Adjustment Due to Systematically Missing Data

    by Savannah L. Bergquist, Thomas G. McGuire, Timothy J. Layton, Sherri Rose

    Objective: To assess the issue of nonrepresentative sampling in Medicare Advantage (MA) risk adjustment.Data Sources: Medicare enrollment and claims data from 2008 to 2011.Data Extraction: Risk adjustment predictor variables were created from 2008 to 2010 Part A and B claims and the Medicare Beneficiary Summary File. Spending is based on 2009–2011 Part A and B, Durable Medical Equipment, and Home Health Agency claims files.Study Design: A propensity‐score matched sample of Traditional Medicare (TM) beneficiaries who resembled MA enrollees was created. Risk adjustment formulas were estimated using multiple techniques, and performance was evaluated based on R2, predictive ratios, and formula coefficients in the matched sample and a random sample of TM beneficiaries.Principal Findings: Matching improved balance on observables, but performance metrics were similar when comparing risk adjustment formula results fit on and evaluated in the matched sample versus fit on the random sample and evaluated in the matched sample.Conclusions: Fitting MA risk adjustment formulas on a random sample versus a matched sample yields little difference in MA plan payments. This does not rule out potential improvements via the matching method should reliable MA encounter data and additional variables become available for risk adjustment.


    • 1 August 2017
      • Vol. 68, 25-38

    Classifying Lung Cancer Severity with Ensemble Machine Learning in Health Care Claims Data.

    by Savannah L Bergquist, Gabriel A Brooks, Nancy L Keating, Mary Beth Landrum, Sherri Rose

    Research in oncology quality of care and health outcomes has been limited by the difficulty of identifying cancer stage in health care claims data. Using linked cancer registry and Medicare claims data, we develop a tool for classifying lung cancer patients receiving chemotherapy into early vs. late stage cancer by (i) deploying ensemble machine learning for prediction, (ii) establishing a set of classification rules for the predicted probabilities, and (iii) considering an augmented set of administrative claims data. We find our ensemble machine learning algorithm with a classification rule defined by the median substantially outperforms an existing clinical decision tree for this problem, yielding full sample performance of 93% sensitivity, 92% specificity, and 93% accuracy. This work has the potential for broad applicability as provider organizations, payers, and policy makers seek to measure quality and outcomes of cancer care and improve on risk adjustment methods.